No insider purchase over the last 90 days. The latest, by 김황필, was filed 09 Jul 2026.
IMB Dx, Inc.: what insiders have been doing
Every trade that managers of IMB Dx, Inc. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. From 10 November 2025 to 10 November 2026, the disclosure feed for IMB Dx, Inc. logged 8 filings by 6 insiders.
Every open-market trade in the period is a purchase: 8 purchases worth €51k, from 6 insiders, and not a single sale. The amount is not disclosed for 7 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 3 board members, 2 senior executives and 1 chief executive. The largest single trade was a purchase of €51k by 송상현, published on 18 June 2026.
Across the 2,630 companies tracked on its exchange, the median is 7 filings; at 8 filings, this issuer sits above that mark. Looking back to 2024, when coverage begins, insiders filed 21 purchases and 4 sales.
The clock since the last published purchase (9 July 2026) now reads 124 days.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 14,681 sharesShareKRXDART:20260709000244Canonical exit: 30 Sept 2026 (T+90)
- 1,311 sharesShareKRXDART:20260707000269Canonical exit: 28 Sept 2026 (T+90)
- 14,000 sharesShareKRXDART:20260630000503Canonical exit: 22 Sept 2026 (T+90)
- 9,600 sharesShareKRXDART:20260630000450Canonical exit: 23 Sept 2026 (T+90)
- 2,255 sharesShareKRXDART:20260629000524Canonical exit: 24 Sept 2026 (T+90)
- 20,001 sharesShareKRXDART:20260618000194Canonical exit: 9 Sept 2026 (T+90)
- 20,001 sharesShareKRXDART:20260618000265Canonical exit: 9 Sept 2026 (T+90)
- 9,890 sharesShareKRXDART:20251222000132Canonical exit: 19 Mar 2026 (T+90)
- 158,502 sharesKRXDART:20240813001164
- 420,000 sharesKRXDART:20240705000443
- 153,421 sharesKRXDART:20240619000052
- 210,000 sharesKRXDART:20240611000532
- 712,975 sharesKRXDART:20240409002552Canonical exit: 2 Jul 2024 (T+90)
- 387,850 sharesShareKRXDART:20240409002245Canonical exit: 2 Jul 2024 (T+90)
- 2,663,050 sharesKRXDART:20240409001890Canonical exit: 2 Jul 2024 (T+90)
- 1,875,000 sharesShareKRXDART:20240409001679Canonical exit: 2 Jul 2024 (T+90)
- 18,925 sharesShareKRXDART:20240409001591Canonical exit: 2 Jul 2024 (T+90)
- 3,775 sharesShareKRXDART:20240409001544Canonical exit: 2 Jul 2024 (T+90)
- 1,375,000 sharesKRXDART:20240408003725Canonical exit: 2 Jul 2024 (T+90)
- 819,825 sharesKRXDART:20240408000549Canonical exit: 2 Jul 2024 (T+90)
- 1,400,000 sharesShareKRXDART:20240405003494Canonical exit: 2 Jul 2024 (T+90)
- 1,057,225 sharesKRXDART:20240405003485Canonical exit: 2 Jul 2024 (T+90)
- 1,400,000 sharesKRXDART:20240405003088Canonical exit: 2 Jul 2024 (T+90)
- 1,871,357 sharesShareKRXDART:20240405001942Canonical exit: 2 Jul 2024 (T+90)
- 1,871,357 sharesKRXDART:20240405001937Canonical exit: 2 Jul 2024 (T+90)
25 of 25 declarations
About IMB Dx, Inc.
아이엠비디엑스 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions in the pharmaceutical field.
